← BackBALCHEM CORP · Chemicals & Allied ProductsBCPC
Low riskNext report: Around Feb 19, 2027 (est.)
The short versionA profitable company with steady sales.
Going well
- Profitable every year for 10 years
- Brings in more cash than it spends
- Little debt
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 1.5% to their holdings in the quarter ending June 2026 (188 bought, 206 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$170.70-3.6% that day
- Company value
- $5.4B
- Share price times all shares
- Price vs profit (P/E)
- 32.1x
- You pay about $32 for each $1 of yearly profit
- Price vs sales
- 4.9x
- Company value is 4.9 times a year of sales
- Dividend yield
- 0.6%
- Yearly dividend as a share of today's price
- Cash vs value
- 1%
- Cash as a share of company value
- Debt vs value
- 0%
- Debt as a share of company value
From BCPC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Sep '26$290.7M+8.6% vs a year earlier
Dec '23Tap a barSep '26
Last 12 months: $1.1B, up 9.4% from the 12 months before. Over 5 years, sales grew about 8.1% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.12.9%
- PassDebt under half of equityNot relying on borrowed money.0.02x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.14.9%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$216.6M
- PassShare count not growingNot diluting owners. Falling means buybacks.+0.7% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.35.7%
- Revenue
- $1.0B
- +8.8% vs prior year
- 5-year growth
- +8.1%/yr
- revenue, per year
- Total debt
- $21.4M
- 0.02x equity
- Current ratio
- 2.07x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Sep 30, 2026Reported Oct 23Before open7:21 am ET - Revenue
- $290.7M
- +8.6% YoY
- EPS
- $1.46
- vs $1.24
- Op. margin
- 21.5%
- +1.1 pts
- Gross margin
- 36.4%
- +0.7 pts
- Free cash flow
- $69.8M
- Share count
- -1.7%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
80/ 100
- This week
- 2
- Normal week
- 0.5
- vs normal
- 4.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady+1.5%Institutions added 1.5% to their holdings. 188 bought, 206 sold. 2 quarters of net buying in a row.
Shares held by institutions29.0M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.5%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.0x · $21.9M debtShares outstandingLatest reported
32MNext reportAround Feb 19, 2027 (est.)Estimated from the same quarter last year
- Results filedOct 23
- Results filedJul 31
- Results filedApr 30
- Results filedFeb 20
- Results filedOct 21, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.